Publications by authors named "Tania A M O Cardoso"

Objective: To evaluate the risk factors and comorbid conditions associated with the development of pneumonia in patients with acute stroke. To determine the independent predictors of pneumonia.

Method: Retrospective study from July to December 2011.

View Article and Find Full Text PDF

Objective: To compare the efficacy of medical and surgical treatment for refractory mesial temporal lobe epilepsy associated with hippocampal sclerosis (MTLE).

Methods: A prospective controlled non-randomized study of 26 patients with MTLE who underwent surgical treatment and 75 patients with MTLE who underwent medical treatment between August 2002 and October 2004. All patients failed to achieve seizure control with at least two first line antiepileptic drugs (AED) for partial seizures before entering the study.

View Article and Find Full Text PDF

Objective: To investigate the value of leaving seizure-free patients on low-dose medication.

Method: This was an exploratory prospective randomized study conducted at our University Hospital. We evaluated the frequency of seizure recurrence and its risk factors following complete or partial antiepileptic drug (AED) withdrawal in seizure free patients for at least two years with focal, secondarily generalized and undetermined generalized epilepsies.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Tania A M O Cardoso"

  • - Tania A M O Cardoso's research primarily focuses on neurological conditions, particularly involving epilepsy, acute stroke, and complications like pneumonia and cerebral venous thrombosis.
  • - Her studies include a comparison of surgical versus medical treatment outcomes in patients with mesial temporal lobe epilepsy, emphasizing the significance of tailored treatment strategies for refractory cases.
  • - Additionally, she investigates the predictors of pneumonia in acute stroke patients and the implications of low antiepileptic drug doses in maintaining long-term seizure freedom, highlighting the complexities of managing neurological disorders.